Further studies should seek to understand the molecular mechanism of the redox-sensitive platelet activation pathways, as this would provide deeper insight and fully elucidate the potential of EC-SOD as a therapeutic agent for pulmonary hypertension. Here, SOD3 is linked to pulmonary arterial hypertension.